Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 25 member 5 pseudogene 9 (SLC25A5P9) is a human gene classified as a pseudogene and does not encode a functional protein product[1][2][3][4][7]. While its protein-coding parent gene (SLC25A5) encodes a mitochondrial adenine nucleotide translocator involved in ATP/ADP exchange, SLC25A5P9 itself is not believed to have transporter activity or to serve as a direct therapeutic target. Pseudogenes, including SLC25A5P9, may have regulatory roles through their RNA—such as acting as competing endogenous RNAs or producing regulatory non-coding RNAs—but there is no specific evidence for such a role for SLC25A5P9[8]. There are no known disease associations, biomarkers, or drugs that interact with SLC25A5P9. Context and notes: - The gene is annotated as a *pseudogene* in all referenced databases[1][3][4][7]. - By definition, pseudogenes like SLC25A5P9 are not considered canonical drug/therapeutic targets, such as receptors, transporters, enzymes, etc.[1][3][4]. - The parent gene (SLC25A5, not SLC25A5P9) belongs to the mitochondrial carrier family and has established function and aliases, but SLC25A5P9 does not encode a protein and has no established role in therapy or disease[1][5]. - The existence of “pseudogene 9” suggests multiple related pseudogenes in the same family—none of which are implied to be functional as targets[5]. - Generally, pseudogenes can sometimes influence gene expression or act as noncoding RNA regulators[8], but specific roles for SLC25A5P9 have not been documented. If you are seeking information about the active transporter encoded by SLC25A5, you should refer instead to "Solute carrier family 25 member 5 (SLC25A5; also known as adenine nucleotide translocator 2)." SLC25A5P9 is a **pseudogene and not a functional target**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 5 pseudogene 9 (SLC25A5P9).